Rheumatology Network News Roundup

January 13, 2017

In this news roundup, we offer a snapshot of some interesting studies we featured that pose never-ending perplexing questions: When do I switch patients from methotrexate to a biologic? Why didn't my patient report having an adverse reaction? Does vitamin D really protect bones?

In this news roundup, we offer a snapshot of some interesting studies we featured that pose never-ending perplexing questions: Â When do I switch patients from methotrexate to a biologic? Why didn't my patient report having an adverse reaction? Does vitamin D really protect bones?

Related Videos

The Future of DSM-5-TR with APA Members Nitin Gogtay, Maria Oquendo, Jonathan Alpert

Daniela Ferrara, MD, PhD: Machine Learning Predicts Functional Outcomes in DME | Image Credit: Ophthalmology Innovation Summit

Ashkan Abbey, MD: 3-Year Efficacy of Pegcetacoplan for Geographic Atrophy | Image Credit: Texas Retina AssociatesImage Credit:

Paul Appelbaum, MD: What to Warn Patients When Prescribing Psychedelics in the Future

Clozapine and Second-Generation Antipsychotics for Schizophrenia, with John Kane, MD

A panel of 5 experts on Cushing's syndrome

Related Content

Digital illustration of cholesterol. | Credit: Fotolia

Long Term Lipoprotein Apheresis Can Reduce Cardiovascular Events for Patients with Elevated Lp(a)

Community-Based Asthma Challenges and Solutions, with Stephanie Lovinsky-Desir, MD, MS

Community-Based Asthma Challenges and Solutions, with Stephanie Lovinsky-Desir, MD, MS

Sarah Kimball, MPH | Credit: New York University

Unstable Housing May Be a Barrier to HCV Treatment Among People Who Inject Drugs

Exploring Procedural Treatments for Dry Eye

Exploring Procedural Treatments for Dry Eye

| Image Credit: Berner Augenklinik

Baseline Features in nAMD Not Predictive of Aflibercept 8 mg Intervals

Only 20% of Patients with Fibromyalgia Report Receiving Satisfactory Information on Pain

Only 20% of Patients with Fibromyalgia Report Receiving Satisfactory Information on Pain

Related Content

Digital illustration of cholesterol. | Credit: Fotolia

Long Term Lipoprotein Apheresis Can Reduce Cardiovascular Events for Patients with Elevated Lp(a)

Community-Based Asthma Challenges and Solutions, with Stephanie Lovinsky-Desir, MD, MS

Community-Based Asthma Challenges and Solutions, with Stephanie Lovinsky-Desir, MD, MS

Sarah Kimball, MPH | Credit: New York University

Unstable Housing May Be a Barrier to HCV Treatment Among People Who Inject Drugs

Exploring Procedural Treatments for Dry Eye

Exploring Procedural Treatments for Dry Eye

| Image Credit: Berner Augenklinik

Baseline Features in nAMD Not Predictive of Aflibercept 8 mg Intervals

Only 20% of Patients with Fibromyalgia Report Receiving Satisfactory Information on Pain

Only 20% of Patients with Fibromyalgia Report Receiving Satisfactory Information on Pain

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.